We are leveraging our
knowledge of new autophagy
biology to create new therapeutics

Our Science

The mission of Samsara is to identify new therapeutics for difficult to treat diseases such as rare genetic disease and neurodegenerative disorders.  We do that by discovering new molecules that restore or induce the process of cellular autophagy.
Our strategy to identify molecules that influence autophagy is via an unbiased screening approach coupled with techniques that enable us to understand mechanism and target.  In this way we are uncovering new biology and ultimately powerful and novel therapeutic agents.

The Lysoseeker™ Platform

A unique approach for discovering new autophagy therapeutics.


What if we could tackle the cause of Alzheimer’s and Parkinson’s Disease?

Rare Monogenic Disease

What if we could offer real hope for serious rare genetic diseases?

Our Pipeline

Samsara is leveraging its knowledge of new autophagy biology.

© 2021 Samsara Therapeutics | Legal Information | Privacy

© 2021 Samsara Therapeutics
Legal Information | Privacy